Dashboard Title: Clinical Trials Analytics
Subtitle: Analyzing Clinical Trials Status and Sponsor Completion
Overall Summary:
This dashboard provides a comprehensive view of the clinical trials landscape, including the status of clinical trials, the sponsors of the trials, and the number of conditions being studied. It shows the percentage of trials that are active, completed, suspended, terminated, withdrawn, and of unknown status. It also shows the percentage of trials sponsored by each of the major pharmaceutical companies. Finally, it shows the number of conditions being studied, from hypertension to diabetes mellitus type 2.
Dashboard Insights:
Get an overview of the clinical trials landscape, including the status of trials, sponsors, and conditions being studied.
See the percentage of trials that are active, completed, suspended, terminated, withdrawn, or of unknown status.
See the percentage of trials sponsored by each of the major pharmaceutical companies.
View the number of conditions being studied, from hypertension to diabetes mellitus type 2.
Who Can Benefit from the Dashboard:
This dashboard is beneficial for anyone who needs to keep track of the clinical trials landscape. It is especially useful for pharmaceutical companies, research institutions, and healthcare providers who need to stay up to date on the status of clinical trials and the sponsors of those trials. It can also be used by researchers to gain insights into the number of conditions being studied.
Who Can Use the Dashboard and How They Would Benefit:
Pharmaceutical companies can use the dashboard to track the status of their clinical trials and the trials sponsored by their competitors.
Research institutions can use the dashboard to track the status of their clinical trials and the trials sponsored by other institutions.
Healthcare providers can use the dashboard to track the status of clinical trials related to their field of practice.
Researchers can use the dashboard to gain insights into the number of conditions being studied.
Clinical Trials
Completed
76.9%
NCTS by Status
Status
Active, not recruiting
Completed
Enrolling by invitation
Not yet recruiting
Recruiting
Suspended
Terminated
Unknown status
Withdrawn
% of NCTs by
Sponsors
Abbvie
Bayer
Gilead
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
‒‒‒‒‒‒‒‒
‒‒‒‒‒‒‒‒‒‒
Terminated
9.3%
1984
1985
1989
1990
1992
[661
1994
1995
1995
061
Withdrawn or Suspended
2.2%
1999
2001
2002
2003
Completed
Terminated
Enrollments by
Hypertension
Hepatitis
Lung
Neoplasms Diabetes mellitus
Type 2
No. of Conditions
Human
Asthma
Arthritis,
Rheumatoid
$8588
Poorini
Anemia
Alzheimer
Disease
Diabetes
Melit
Breast
Neoplaus
Pulmonary
885 887FA